GSK agreed to confidentially settle another lawsuit in California that had alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of settlements made by the British drugmaker to end costly litigation. The case, which was set to begin trial on April 2, will be dismissed. GSK does not admit to any liability in this settlement with Boyd/Steenvoord, it said on Thursday.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Evergrande Group reports growth

Shanghai: On Dec 26, China Evergrande Group disclosed that it had made…

First female MD of Falcon-i

Farha Naz is appointed as the first female managing director of Falco-i,…

Flour Mills will resume operations on Feb 14: Reports

Lahore: Punjab Flour Mills Association (PFMA) announced calling off strike it had…

Pakistan’s economy witnessed a record growth: Asad Umar

Faisalabad: Federal Minister for Planning, Development, and Special Initiatives Asad Umar claimed…